Altre lingue InterCure Ltd.

Azioni

INCR

IL0011063760

Tempo differito TEL AVIV STOCK EXCHANGE Altri mercati azionari 14:53:18 10/07/2024			Variaz. 5gg	Var. 1 gen.
853,1 ^ILa	+0,35%		+9,09%	+84,22%

01/05	InterCure Ltd. Fornisce una previsione di fatturato per l'intero anno 2024	CI
01/05	InterCure Ltd. Riporta i risultati degli utili per l'intero anno terminato il 31 dicembre 2023	CI

Altre lingue

Sblocca tutte le notizie: sii il primo a essere informato e reagisci prima dei mercati!

Registrazione 100% gratuita

InterCure to Participate in Canaccord Genuity’s 8th Annual Global Cannabis Conference	22/05
InterCure : Immediate Report	21/05
InterCure Announces FY2023 Results: Revenue of NIS 356 million and Adjusted EBITDA of NIS 61 million	01/05
InterCure Ltd. Provides Revenue Guidance for the Full Year 2024	01/05
InterCure : FORM 20-F For the fiscal year ended December 31, 2023	01/05
InterCure : Announces FY2023 Result	01/05
InterCure Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	01/05
InterCure : Preliminary results for the full year of 2023	01/04
InterCure Announces Preliminary Estimated 2023 Revenue of NIS 351 million and EBITDA of over NIS 50 million	01/04
InterCure Ltd. Provides Earnings Guidance for the Second Half and Full Year of 2023	01/04
InterCure : Announces Preliminary Estimated 2023 Revenue of NIS 351 million and EBIDTA of over NIS 50 million - Form 6-K	01/04
InterCure Congratulates Germany on Cannabis Reform, Expanding its Global Footprint	22/03
InterCure Ltd. Expects to Launch Its First Products in Germany in the Coming Months	22/03
InterCure Provides an Update Regarding Nir Oz Facility	13/02
InterCure Ltd. Announces Resignation of Rami Levy as Chief of Operations	13/02
InterCure Signs Definitive Agreement to Acquire Leon Cannabis Pharmacy Chain	31/01
InterCure Ltd. entered into a share purchase agreement to acquire Leon Pharm Ltd for ILS 8.3 million.	31/01
InterCure : NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON DECEMBER 14, 2023 - Form 6-K	08/11
InterCure Wins Cannolam Arbitration Proceeding	31/10/23
InterCure Provides an Update Regarding the Security Situation in Israel	17/10/23

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue InterCure Ltd.

Azioni

INCR

IL0011063760

Altre lingue

Filtri